Novel 2‐Phenyl‐1 H ‐Pyrrole Derivatives as Mitochondrial Pyruvate Carrier Inhibitors to Treat Hair Loss
Chemical Biology & Drug Design · 2026-06 · 107 (6)
DOI: 10.1111/cbdd.70306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 23.06.2026. Verfasst von Xingyu Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai, China. Hauptthemen laut MEDLINE: Alopecia, Pyrroles, Mitochondrial Membrane Transport Proteins, Monocarboxylic Acid Transporters. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Science and Technology Major Project, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Hair follicle stem cells (HFSCs) play the primary role in the regulation of the hair growth cycle. Premature termination of the anagen phase accelerates the transition of hair follicles into the catagen and telogen phases, leading to hair loss. Inhibiting the mitochondrial pyruvate carrier (MPC), which prevents pyruvate from entering mitochondria, enhances lactate synthesis. This activates HFSCs and initiates a new hair growth cycle. To develop safer and more effective MPC inhibitors, we designed and synthesized a series of 2‐phenyl‐1 H ‐pyrrole derivatives based on UK5099 and JXL066 by scaffold hopping and structural optimization strategies. In vitro lactate release assay identified 14 compounds that exhibited superior biological activity compared to UK5099, with 5a being the most potent compound. The ADMET predictions suggested that 5a possesses low toxicity and moderate skin permeability, supporting its suitability for topical dermal formulations. Further evaluation demonstrated 5a had good stability in topical formulation and low skin irritation in repeated acute irritation tests. Hair regrowth experiments in C57BL/6J mice showed that 5a significantly promoted hair regrowth and accelerated the transition from telogen to anagen, accompanied by increased hair follicle density. These findings validate MPC as a promising target and highlight 5a as a potential therapeutic agent for the treatment of hair loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai, China.
- National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., Shanghai, China.
- School of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, China.
ORCID-Profile: Bo Han, Qingwei Zhang
Förderung
- National Science and Technology Major Project
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- National Key Laboratory of Lead Druggability Research
Zitieren
APA
Wu, X., Zhang, H., Huang, Y., Han, B., Li, M., & Zhang, Q. (2026). Novel 2‐Phenyl‐1 H ‐Pyrrole Derivatives as Mitochondrial Pyruvate Carrier Inhibitors to Treat Hair Loss. Chemical Biology & Drug Design, 107(6). https://doi.org/10.1111/cbdd.70306
Vancouver
Wu X, Zhang H, Huang Y, Han B, Li M, Zhang Q. Novel 2‐Phenyl‐1 H ‐Pyrrole Derivatives as Mitochondrial Pyruvate Carrier Inhibitors to Treat Hair Loss. Chemical Biology & Drug Design. 2026;107(6). doi:10.1111/cbdd.70306
BibTeX
@article{Wu2026,
author = {Wu, Xingyu and Zhang, Han and Huang, Yilei and Han, Bo and Li, Misi and Zhang, Qingwei},
title = {Novel 2‐Phenyl‐1 H ‐Pyrrole Derivatives as Mitochondrial Pyruvate Carrier Inhibitors to Treat Hair Loss},
journal = {Chemical Biology & Drug Design},
year = {2026},
volume = {107},
number = {6},
doi = {10.1111/cbdd.70306}
}
EUVIMED